stoxline Quote Chart Rank Option Currency Glossary
  
Waters Corporation (WAT)
347.27  -5.63 (-1.6%)    03-18 16:00
Open: 350.11
High: 355.59
Volume: 377,094
  
Pre. Close: 352.9
Low: 347.11
Market Cap: 20,559(M)
Technical analysis
2024-03-18 4:48:13 PM
Short term     
Mid term     
Targets 6-month :  424.9 1-year :  496.29
Resists First :  363.79 Second :  424.9
Pivot price 347.5
Supports First :  328.81 Second :  307.2
MAs MA(5) :  349.75 MA(20) :  342.74
MA(100) :  305.2 MA(250) :  288.3
MACD MACD :  7.3 Signal :  7.8
%K %D K(14,3) :  57.6 D(3) :  61.2
RSI RSI(14): 56
52-week High :  363.79 Low :  231.89
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ WAT ] has closed above bottom band by 49.2%. Bollinger Bands are 16.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 356.6 - 358.57 358.57 - 360.18
Low: 340.99 - 343.79 343.79 - 346.07
Close: 343.17 - 347.3 347.3 - 350.66
Company Description

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Headline News

Mon, 18 Mar 2024
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch

Mon, 18 Mar 2024
Waters Co. (NYSE:WAT) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat

Mon, 18 Mar 2024
Waters (WAT) Boosts PFAS Testing Solutions With New Cartridges - Yahoo Finance

Mon, 18 Mar 2024
Diversified Trust Co Raises Holdings in Waters Co. (NYSE:WAT) - Defense World

Mon, 18 Mar 2024
Waters Co. (NYSE:WAT) Shares Sold by Vanguard Group Inc. - Defense World

Fri, 15 Mar 2024
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Diagnostics & Research
Shares Out 59 (M)
Shares Float 59 (M)
Held by Insiders 0.3 (%)
Held by Institutions 102.1 (%)
Shares Short 3,980 (K)
Shares Short P.Month 4,040 (K)
Stock Financials
EPS 10.85
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 19.44
Profit Margin 21.7 %
Operating Margin 36.9 %
Return on Assets (ttm) 13.5 %
Return on Equity (ttm) 77.6 %
Qtrly Rev. Growth -4.5 %
Gross Profit (p.s.) 0
Sales Per Share 50
EBITDA (p.s.) 17.22
Qtrly Earnings Growth -4.2 %
Operating Cash Flow 603 (M)
Levered Free Cash Flow 444 (M)
Stock Valuations
PE Ratio 31.97
PEG Ratio 6
Price to Book value 17.86
Price to Sales 6.94
Price to Cash Flow 34.1
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android